SCHEMBL28512585

SCHEMBL28512585

ClC1[CH]OCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2039246 0.82
SCHEMBL16466504 0.63 ALDH1A1 (0.33)
SCHEMBL19094737 0.62
SCHEMBL16027843 0.62
SCHEMBL16632235 0.60 CHRM2 (0.34)
SCHEMBL11289895 0.59 ALDH1A1 (0.31)
SCHEMBL11276576 0.59
SCHEMBL1714380 0.59
SCHEMBL11289901 0.59 ALDH1A1 (0.31)
SCHEMBL17845576 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112236431-B Purinone Compounds and Their Use in the Treatment of Cancer 阿斯利康(瑞典)有限公司 2024-02-13 CN disclosed
CN-110177791-B Amino-triazolopyridine compounds and their use in the treatment of cancer 阿斯利康(瑞典)有限公司 2022-07-12 CN disclosed
CN-112236431-A Purinone compounds and their use in the treatment of cancer 阿斯利康(瑞典)有限公司 2021-01-15 CN disclosed